<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Benzylpiperazine,Stimulants,Stimulants,Sympathomimetic amines,1-methyl-4-benzylpiperazine,1944,1970s,1980s,5-Hydroxytryptophan,ATC code,Adrafinil" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Benzylpiperazine - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Benzylpiperazine</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table border="1" cellpadding="3" cellspacing="0" width="250px" align="right" style="border-collapse: collapse; margin: 0 0 0 0.5em">
<tr>
<td bgcolor="#FFFFFF" align="center" colspan="2">
<p><a href="../../../b/e/n/Image%7EBenzylpiperazine.jpg_6ee6.html" class="image" title="Benzylpiperazine chemical structure"><img src="../../../upload/thumb/1/19/Benzylpiperazine.jpg/200px-Benzylpiperazine.jpg" alt="Benzylpiperazine chemical structure" width="200" height="80" longdesc="../../../b/e/n/Image%7EBenzylpiperazine.jpg_6ee6.html" /></a><br />
<i>Benzylpiperazine (BZP)</i></p>
</td>
</tr>
<tr>
<td align="center" colspan="2"><i><a href="../../../i/u/p/IUPAC_nomenclature_27e6.html" title="IUPAC nomenclature">IUPAC name</a></i>:
<p><i>N-Benzylpiperazine</i></p>
</td>
</tr>
<tr align="center" style="border-bottom: 3px solid gray">
<td><b><a href="../../../c/a/s/CAS_number_b7cb.html" title="CAS number">CAS number</a></b><br />
2759-28-6</td>
<td><b><a href="../../../a/t/c/ATC_code_3c84.html" title="ATC code">ATC code</a></b><br />
&#160;?</td>
</tr>
<tr>
<td bgcolor="#EEEEEE"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Chemical formula</a></td>
<td bgcolor="#DDEEFF">C<sub>11</sub>H<sub>16</sub>N<sub>2</sub></td>
</tr>
<tr>
<td bgcolor="#EEEEEE"><a href="../../../m/o/l/Molecular_weight.html" title="Molecular weight">Molecular weight</a></td>
<td bgcolor="#DDEEFF">176.26</td>
</tr>
<tr>
<td bgcolor="#EEEEEE"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#DDEEFF">&#160;?</td>
</tr>
<tr>
<td bgcolor="#EEEEEE">Metabolism</td>
<td bgcolor="#DDEEFF">Primarily hydroxylation (<a href="../../../h/e/p/Hepatic.html" title="Hepatic">hepatic</a>?)</td>
</tr>
<tr>
<td bgcolor="#EEEEEE"><a href="../../../e/l/i/Elimination_half-life.html" title="Elimination half-life">Elimination half-life</a></td>
<td bgcolor="#DDEEFF">A few hours (estimate)</td>
</tr>
<tr>
<td bgcolor="#EEEEEE"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#DDEEFF">Primarily <a href="../../../u/r/i/Urine.html" title="Urine">urinary</a></td>
</tr>
<tr>
<td bgcolor="#EEEEEE"><a href="../../../p/r/e/Pregnancy_category_%28pharmaceutical%29.html" title="Pregnancy category (pharmaceutical)">Pregnancy category</a></td>
<td bgcolor="#DDEEFF">Uncategorised</td>
</tr>
<tr>
<td bgcolor="#EEEEEE"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#DDEEFF">Varies; <a href="../../../d/r/u/Drug_Enforcement_Administration_8665.html" title="Drug Enforcement Administration">DEA</a> Schedule 1 drug; legal in some countries</td>
</tr>
<tr>
<td bgcolor="#EEEEEE">Routes of administration</td>
<td bgcolor="#DDEEFF"><a href="http://en.wiktionary.org/wiki/oral" class="extiw" title="wiktionary:oral">Oral</a></td>
</tr>
</table>
<p><b>Benzylpiperazine</b> (<b>BZP</b>) is a <a href="../../../r/e/c/Recreational_drug.html" title="Recreational drug">recreational drug</a> with <a href="../../../e/u/p/Euphoria.html" title="Euphoria">euphoric</a>, <a href="../../../s/t/i/Stimulant.html" title="Stimulant">stimulant</a> effects. It is banned in a few countries, including the <a href="../../../u/n/i/United_States_09d4.html" title="United States">United States</a>, <a href="../../../a/u/s/Australia.html" title="Australia">Australia</a> and in parts of <a href="../../../e/u/r/Europe.html" title="Europe">Europe</a>. However, its legal status is less restrictive in some other countries such as the <a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">United Kingdom</a> and <a href="../../../n/e/w/New_Zealand_2311.html" title="New Zealand">New Zealand</a> and Canada. (see below).</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Production"><span class="tocnumber">2</span> <span class="toctext">Production</span></a></li>
<li class="toclevel-1"><a href="#Effects"><span class="tocnumber">3</span> <span class="toctext">Effects</span></a>
<ul>
<li class="toclevel-2"><a href="#Subjective_Effects"><span class="tocnumber">3.1</span> <span class="toctext">Subjective Effects</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Tolerance"><span class="tocnumber">4</span> <span class="toctext">Tolerance</span></a></li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">5</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1"><a href="#Toxic_effects_of_BZP_in_humans"><span class="tocnumber">6</span> <span class="toctext">Toxic effects of BZP in humans</span></a></li>
<li class="toclevel-1"><a href="#Addictive_Effects"><span class="tocnumber">7</span> <span class="toctext">Addictive Effects</span></a></li>
<li class="toclevel-1"><a href="#Legal_issues"><span class="tocnumber">8</span> <span class="toctext">Legal issues</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">9</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>It is often mistakenly claimed that BZP was originally synthesized in <a href="../../../1/9/4/1944.html" title="1944">1944</a> as a potential <a href="../../../a/n/t/Anthelmintic.html" title="Anthelmintic">anthelmintic</a> (anti-parasitic) agent for use in farm animals. However, a paper received for publication in August 1943 refers to benzylpiperazine and references the removal of benzyl groups from piperazines as early as 1941. References to BZP in the literature predate interest in piperazines as anthelmintics. The earliest clinical trials in the literature relating to <a href="../../../p/i/p/Piperazine.html" title="Piperazine">piperazine</a> use as an <a href="../../../a/n/t/Anthelmintic.html" title="Anthelmintic">anthelmintic</a> are two articles in the British Medical Journal in 1953.</p>
<p>BZP next crops up in the literature when a few studies examined its stimulant effects in the <a href="../../../1/9/7/1970s.html" title="1970s">1970s</a> and <a href="../../../1/9/8/1980s.html" title="1980s">1980s</a>.</p>
<p>In the early 1990s, the United States <a href="../../../d/r/u/Drug_Enforcement_Administration_8665.html" title="Drug Enforcement Administration">Drug Enforcement Administration</a> noted the drug was being used recreationally in <a href="../../../c/a/l/California.html" title="California">California</a>. It also reported that BZP was being used as an <a href="../../../a/d/u/Adulterant.html" title="Adulterant">adulterant</a> in illicit drugs. Not long after, there was an explosion in the drug's use worldwide — a situation which was soon followed by legislative control in many countries. Piperazine based stimulants had remained virtually unavailable in places such as Canada until recently. In early 2006 pills containing the active ingredients BZP and TFMPP first began to appear in the city of Vancouver where they quickly gained popularity with late-night partygoers as a safer alternative to the illicit street drugs currently available there. BZP based "Legal Highs" are marketed to Canadians under the name "Lovely" and the pills are often referred to as "Lovelies" by the locals.</p>
<p><a name="Production" id="Production"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Production">edit</a>]</span> <span class="mw-headline">Production</span></h2>
<div class="floatleft"><span><a href="../../../b/z/p/Image%7EBzp_brands.jpg_2c1d.html" class="image" title="A selection of products containing BZP. Legally available throughout New Zealand."><img src="../../../upload/thumb/7/72/Bzp_brands.jpg/150px-Bzp_brands.jpg" alt="A selection of products containing BZP. Legally available throughout New Zealand." width="150" height="103" longdesc="../../../b/z/p/Image%7EBzp_brands.jpg_2c1d.html" /></a></span></div>
<p>Where legal, BZP is often produced in small specialist laboratories. The raw materials can be purchased from various chemical supply agencies and formed into tablets or capsules using relatively cheap production techniques. The resulting product can be marketed at extremely high <a href="../../../m/a/r/Markup_%28business%29.html" title="Markup (business)">markup</a> (end-user prices can be as high as 300 times the bulk cost of raw ingredients).</p>
<p>BZP is often marketed ostensibly as a "dietary supplement" to avoid meeting stricter laws that apply to medicines and drugs, despite the fact that BZP has no dietary value. It is worth noting however that as of late 2005 it can no longer be classified or marketed as a dietary supplement in New Zealand.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup></p>
<p>Well over 20 million pills containing BZP have been consumed in New Zealand with no available record attributing deaths or lasting injuries to BZP toxicity.</p>
<p>Some retailers claim that BZP is a "natural" product, describing it as a "pepper extract" or "herbal high." In fact, the drug is entirely <a href="../../../c/h/e/Chemical_synthesis.html" title="Chemical synthesis">synthetic</a>, and does not occur naturally.</p>
<p><a name="Effects" id="Effects"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Effects">edit</a>]</span> <span class="mw-headline">Effects</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:77px;"><a href="../../../e/y/e/Image%7EEye_bzp.jpg_454f.html" class="internal" title="Typical pupil dilation"><img src="../../../upload/1/19/Eye_bzp.jpg" alt="Typical pupil dilation" width="75" height="100" longdesc="../../../e/y/e/Image%7EEye_bzp.jpg_454f.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../e/y/e/Image%7EEye_bzp.jpg_454f.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Typical pupil dilation</div>
</div>
</div>
<p>The effects of BZP are largely similar to <a href="../../../d/e/x/Dextroamphetamine.html" title="Dextroamphetamine">dextroamphetamine</a>.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup> Users report alertness, euphoria and a general feeling of well being. The perception of certain sensations such as taste, colour or music may be subjectively enhanced. The average duration is longer than that of dextroamphetamine, typically lasting 4-6 hours with reports as long as 8 hours depending on the dose.</p>
<p>A recent study has shown that mixtures of BZP with other piperazine drugs such as <a href="../../../t/r/i/Trifluoromethylphenylpiperazine.html" title="Trifluoromethylphenylpiperazine">TFMPP</a> share certain <a href="../../../p/h/a/Pharmacodynamic.html" title="Pharmacodynamic">pharmacodynamic</a> traits with <a href="../../../m/d/m/MDMA_8cbe.html" title="MDMA">MDMA</a>.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup></p>
<p>As with most <a href="../../../s/y/m/Sympathomimetic.html" title="Sympathomimetic">sympathomimetic</a> <a href="../../../s/t/i/Stimulant.html" title="Stimulant">stimulants</a> there appear to be significant side effects associated with BZP use. BZP reportedly produces insomnia and a severe <a href="../../../h/a/n/Hangover.html" title="Hangover">hangover</a> after the drug effect wears off, however some manufacturers in New Zealand have started including recovery pills which contain <a href="../../../5/-/h/5-Hydroxytryptophan_458d.html" title="5-Hydroxytryptophan">5-HTP</a> and vitamins which allegedly ease these hangovers. Other side effects include dilated pupils, dryness of the mouth, reduced appetite, teeth clenching and problems with <a href="../../../u/r/i/Urine_retention.html" title="Urine retention">urine retention</a>.</p>
<p><a name="Subjective_Effects" id="Subjective_Effects"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Subjective Effects">edit</a>]</span> <span class="mw-headline">Subjective Effects</span></h3>
<p>Upon ingestion of between 50 mg and 200 mg of BZP, the user may experience any or all of the following:</p>
<p>Coming up:</p>
<ul>
<li>Changes in body temperature</li>
<li>Slight <a href="../../../n/a/u/Nausea.html" title="Nausea">nausea</a></li>
<li><a href="../../../f/l/u/Flushing_%28physiology%29.html" title="Flushing (physiology)">Flushing</a></li>
<li>Rapid mood elevation</li>
<li>Increased heart rate</li>
<li><a href="../../../d/i/l/Dilation.html" title="Dilation">Dilation</a> of <a href="../../../p/u/p/Pupil.html" title="Pupil">pupils</a> (see photo)</li>
<li>Decreased <a href="../../../a/p/p/Appetite.html" title="Appetite">appetite</a></li>
<li>"Rushing" sensation<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li>Mild to moderate <a href="../../../s/y/n/Synesthesia.html" title="Synesthesia">synesthesia</a><sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li>Skin tingling</li>
<li>Feelings of <a href="../../../e/u/p/Euphoria.html" title="Euphoria">euphoria</a>, wonder, amazement, elation</li>
<li>Increased desire to move<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li>Closed-eye <a href="../../../h/a/l/Hallucinations.html" title="Hallucinations">hallucinations</a> with music<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li>Temporary impotence<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li>Time Dysmorphia<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
</ul>
<p>Coming down:</p>
<ul>
<li>Reduced sexual sensation - erectile dysfunction is not uncommon despite urges</li>
<li>Mild <a href="../../../h/e/a/Headache.html" title="Headache">headache</a></li>
<li><a href="../../../h/a/n/Hangover.html" title="Hangover">Hangover</a>-like symptoms (common with high doses)</li>
<li><a href="../../../f/a/t/Fatigue_%28physical%29.html" title="Fatigue (physical)">Fatigue</a></li>
<li><a href="../../../i/n/s/Insomnia.html" title="Insomnia">Insomnia</a></li>
<li><a href="../../../c/o/n/Confusion.html" title="Confusion">Confusion</a> (with higher doses)</li>
<li>Mild memory loss</li>
<li>Gradual reduction of effects in the "coming up" phase</li>
</ul>
<p><a name="Tolerance" id="Tolerance"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Tolerance">edit</a>]</span> <span class="mw-headline">Tolerance</span></h2>
<p>Research into BZP's tolerance is sparse. Anecdotal evidence from online sources claim if 100–200 mg of BZP is taken daily, tolerance to the drug begins on day seven.<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup> Due to tiredness associated with the body's recovery from stimulants, such as BZP, it is uncommon for users to be able to sustain a week long intake.</p>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<p>BZP has been shown to have a mixed mechanism of action, acting on the <a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonergic</a> and <a href="../../../d/o/p/Dopamine.html" title="Dopamine">dopaminergic</a> receptor systems. BZP has amphetamine-like actions on the <a href="../../../m/o/n/Monoamine_transporter.html" title="Monoamine transporter">serotonin reuptake transporter</a>, which increase serotonin concentrations in the extracellular fluids surrounding the <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cell</a> and thereby increasing activation of the surrounding serotonin receptors. BZP also has a lower potency effect on the <a href="../../../m/o/n/Monoamine_transporter.html" title="Monoamine transporter">noradrenaline reuptake transporter</a> and the <a href="../../../m/o/n/Monoamine_transporter.html" title="Monoamine transporter">dopamine reuptake transporter</a>. BZP also has a high affinity action at the <a href="../../../a/d/r/Adrenoceptor.html" title="Adrenoceptor">alpha2-adrenoreceptor</a>. BZP is an antagonist at the receptor, like <a href="../../../y/o/h/Yohimbine.html" title="Yohimbine">yohimbine</a>, which inhibits negative feedback, causing an increase in released <a href="../../../n/o/r/Noradrenaline.html" title="Noradrenaline">noradrenaline</a>. BZP also acts as a non-selective <a href="../../../s/e/r/Serotonin_receptor.html" title="Serotonin receptor">serotonin receptor</a> <a href="../../../a/g/o/Agonist.html" title="Agonist">agonist</a> on a wide variety of serotonin receptors; binding to 5HT<sub>2A</sub> receptors may explain its hallucinogenic effects at high doses, while partial agonist or antagonist effects at the 5HT<sub>2B</sub> receptors may explain some of BZPs peripheral side effects, as this receptor is expressed very densely in the gut, and binding to 5HT<sub>3</sub> receptors may explain the common side effect of headaches, as this receptor is known to be involved in the development of <a href="../../../m/i/g/Migraine.html" title="Migraine">migraine</a> headaches.</p>
<p><a name="Toxic_effects_of_BZP_in_humans" id="Toxic_effects_of_BZP_in_humans"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Toxic effects of BZP in humans">edit</a>]</span> <span class="mw-headline">Toxic effects of BZP in humans</span></h2>
<p>From 1 April 2005 to 1 September 2005 all presentations associated with party pill use at the Emergency Department of Christchurch Hospital, New Zealand were captured on a prospective data collection form. The aim was to study the patterns of human toxicity related to the use of 1-benzylpiperazine (BZP)-based 'party pills'. 61 patients presented on 80 occasions.</p>
<ul>
<li>Patients with mild to moderate toxicity experienced symptoms such as <a href="../../../i/n/s/Insomnia.html" title="Insomnia">insomnia</a>, <a href="../../../a/n/x/Anxiety.html" title="Anxiety">anxiety</a>, <a href="../../../n/a/u/Nausea.html" title="Nausea">nausea</a>, <a href="../../../v/o/m/Vomiting.html" title="Vomiting">vomiting</a>, <a href="../../../p/a/l/Palpitations.html" title="Palpitations">palpitations</a>, <a href="../../../d/y/s/Dystonia.html" title="Dystonia">dystonia</a>, and <a href="../../../u/r/i/Urinary_retention.html" title="Urinary retention">urinary retention</a>.</li>
</ul>
<ul>
<li>Fifteen toxic <a href="../../../s/e/i/Seizures.html" title="Seizures">seizures</a> were recorded.</li>
</ul>
<ul>
<li>Two patients suffered life-threatening <a href="../../../t/o/x/Toxicity.html" title="Toxicity">toxicity</a> with <a href="../../../s/t/a/Status_epilepticus.html" title="Status epilepticus">status epilepticus</a> and severe respiratory and <a href="../../../m/e/t/Metabolic_acidosis.html" title="Metabolic acidosis">metabolic acidosis</a>.</li>
</ul>
<p>The results of this study indicate that BZP can cause unpredictable and serious toxicity in some individuals.</p>
<p>However, a recent study in New Zealand cleared BZP as a cause of a variety of adverse effects, stating that it wasn't to be connected with life threatening seizures in neurologically normal subjects.<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup></p>
<p>Two deaths have been officially recorded in connection with the use of BZP.<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[5]</a></sup><sup id="_ref-5" class="reference"><a href="#_note-5" title="">[6]</a></sup> In both cases, the individual had consumed a quantity of BZP as well as MDMA, and in the first case she had consumed over 10 litres of water, while in the second case a large quantity of alcohol had been consumed. The first individual subsequently died of <a href="../../../c/e/r/Cerebral_edema.html" title="Cerebral edema">cerebral edema</a> due to <a href="../../../h/y/p/Hyponatremia.html" title="Hyponatremia">hyponatremia</a> resulting from <a href="../../../w/a/t/Water_intoxication.html" title="Water intoxication">water intoxication</a>, while the cause of death of the second individual has not been released. It is uncertain what role the BZP may have had in these deaths; while it should be noted that death from hyponatremia is a well known consequence of drinking too much fluids after consuming MDMA, it is likely that the additional hyponatremic effects from the BZP may have increased the hyponatremic effects from the MDMA, to the point that death resulted. In both cases the actual cause of death appears likely to be fluid intoxication with the drugs as a secondary exacerbating factor, and so these individuals lives could have been saved if they had been given electrolyte drinks or salt when the first signs of hyponatremia appeared, and even when hyponatremia is quite advanced it can usually be reversed by intravenous saline, so it is unfortunate that these individuals did not receive appropriate medical attention quickly enough to save them.</p>
<p><a name="Addictive_Effects" id="Addictive_Effects"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Addictive Effects">edit</a>]</span> <span class="mw-headline">Addictive Effects</span></h2>
<p>1 in every 45 (2.2%) last year users of BZP in New Zealand is classed as dependent upon it, although 97.9% of users said that "it would not be difficult to stop using legal party pills", and 45.2% of people who reported using both BZP and illegal drugs such as methamphetamine reported that they used BZP so that they did not have to use methamphetamine, which was perceived as more harmful.<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[7]</a></sup> Studies undertaken on animals have indicated that BZP can substitute for methamphetamine in addicted rats, although it is ten times less potent and produces correspondingly weaker addictive effects.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[8]</a></sup></p>
<p><a name="Legal_issues" id="Legal_issues"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: Legal issues">edit</a>]</span> <span class="mw-headline">Legal issues</span></h2>
<p>The drug was classified as a Schedule I <a href="../../../c/o/n/Controlled_substance.html" title="Controlled substance">controlled substance</a> in the United States in 2002, following a report by the <a href="../../../d/r/u/Drug_Enforcement_Administration_8665.html" title="Drug Enforcement Administration">DEA</a> which incorrectly stated that BZP was ten times <i>more</i> potent than dexamphetamine, when in fact BZP is ten times <i>less</i> potent than dexamphetamine. The DEA subsequently admitted this mistake, but nevertheless retained the Schedule 1 classification. BZP is banned in all Australian states. Victoria, the last state in which it was legal, changed its classification on September 1 2006. This is the date BZP and piperazine analogs become illegal in the federal schedules which are now enacted by all Australian states and territories. BZP is also a banned substance in Japan, along with TFMPP. Both Australia and Japan admit that their scheduling decisions were made primarily in response to the Schedule 1 classification given to BZP in the USA, although some instances of BZP use had been reported by law enforcement authorities in both countries.</p>
<p><a href="../../../p/i/p/Piperazine.html" title="Piperazine">Piperazine</a> and salts of <a href="../../../p/i/p/Piperazine.html" title="Piperazine">piperazine</a> are classified as Prescription Only Medicines in the <a href="../../../u/k/_/UK_7642.html" title="UK">UK</a>. Any products containing salts of <a href="../../../p/i/p/Piperazine.html" title="Piperazine">piperazine</a> would be licensable under the <a href="../../../m/e/d/Medicines_Act_aa1d.html" title="Medicines Act">Medicines Act</a><sup id="_ref-8" class="reference"><a href="#_note-8" title="">[9]</a></sup> and consequently anyone manufacturing and supplying it legally must hold the relevant licences to do so. BZP is not a salt of <a href="../../../p/i/p/Piperazine.html" title="Piperazine">piperazine</a>, but mislabelling of BZP products as containing "piperazine blend" (perhaps in a poorly judged attempt by marketers to conceal the identity of the active ingredient from competitors) has resulted in some prosecutions of suppliers in the UK by the Medicines and Healthcare Products Regulatory Agency.<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[10]</a></sup></p>
<p>In some other places (such as <a href="../../../n/e/w/New_Zealand_2311.html" title="New Zealand">New Zealand</a>), BZP is legal. It is classed in New Zealand as a "Restricted Substance" by the Misuse of Drugs Act and restricted to those over 18 years.<sup id="_ref-10" class="reference"><a href="#_note-10" title="">[11]</a></sup> Products containing BZP are marketed by manufacturers and sellers as a harm-reduction measure, however the legislation is currently under review pending the findings of a number of research projects into the effects of the drug. Research into the long term effects of BZP use are scarce. To date, the drug has been considered to be of low risk of harm to users, but more information is required, and the New Zealand government is considering introducing tighter restrictions in 2007. BZP and <a href="../../../t/f/m/TFMPP_429b.html" title="TFMPP">TFMPP</a> are legal and uncontrolled recreational drugs in many countries such as Canada, Ireland, New Zealand and the United Kingdom,<sup id="_ref-11" class="reference"><a href="#_note-11" title="">[12]</a></sup> and are not controlled under any UN convention, so the compounds themselves are legal throughout most of the world, although in most countries their use is restricted to pharmaceutical manufacturing and recreational use is unknown. <a href="http://www.erowid.org/chemicals/bzp/bzp_law.shtml" class="external text" title="http://www.erowid.org/chemicals/bzp/bzp_law.shtml" rel="nofollow">Legality</a></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../t/f/m/TFMPP_429b.html" title="TFMPP">TFMPP</a></li>
<li><a href="../../../m/c/p/MCPP_7d44.html" title="MCPP">mCPP</a></li>
<li><a href="../../../m/e/o/MeOPP_a0f1.html" title="MeOPP">MeOPP</a></li>
<li><a href="../../../p/f/p/PFPP_5d25.html" title="PFPP">pFPP</a></li>
<li><a href="../../../1/-/m/1-methyl-4-benzylpiperazine.html" title="1-methyl-4-benzylpiperazine">MBZP</a></li>
<li><a href="../../../p/a/r/Party_pills.html" title="Party pills">Party pills</a></li>
<li><a href="../../../p/i/p/Piperazine.html" title="Piperazine">Piperazine</a></li>
<li><a href="../../../d/r/u/Drug_abuse.html" title="Drug abuse">Drug abuse</a></li>
<li><a href="../../../r/e/c/Recreational_drugs.html" title="Recreational drugs">Recreational drugs</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <span class="PDFlink"><a href="http://www.stanz.org.nz/images/ASSENT81.PDF" class="external text" title="http://www.stanz.org.nz/images/ASSENT81.PDF" rel="nofollow">Misuse of Drugs Amendment Act 2005</a></span><small><a href="../../../p/o/r/Portable_Document_Format_95a8.html" title="Portable Document Format">PDF</a>&#160;(81.3&#160;<a href="../../../k/i/b/Kibibyte.html" title="Kibibyte">KiB</a>)</small></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> One study found that former amphetamine addicts were unable to distinguish between d-amphetamine and BZP administered intravenously. ("Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts." <i>Eur J Clin Pharmacol.</i> 1973 Oct;6(3):170-6.)</li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> "N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')." <i>Neuropsychopharmacology</i>. 2005 Mar;30(3):550-60.</li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> Gee P, Richardson S, Woltersdorf W, Moore G. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16372033&amp;query_hl=2&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16372033&amp;query_hl=2&amp;itool=pubmed_docsum" rel="nofollow">Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand.</a> <i>New Zealand Medical Journal</i>. 2005 Dec 16;118(1227):U1784.</li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> Balmelli C, Kupferschmidt H, Rentsch K, Schneemann M. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11499262" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11499262" rel="nofollow">Fatal brain edema after ingestion of ecstasy and benzylpiperazine</a>. <i>Dtsch Med Wochenschr</i>. 2001 Jul 13;126(28-29):809-11.</li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> <a href="http://www.nzherald.co.nz/section/1/story.cfm?c_id=1&amp;objectid=10418032" class="external free" title="http://www.nzherald.co.nz/section/1/story.cfm?c_id=1&amp;objectid=10418032" rel="nofollow">http://www.nzherald.co.nz/section/1/story.cfm?c_id=1&amp;objectid=10418032</a></li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> <span class="PDFlink"><a href="http://www.spiritualhigh.co.uk/spiritualhigh.co.uk/downloads/Legal-party-pills-in-New-Zealand-report.pdf" class="external autonumber" title="http://www.spiritualhigh.co.uk/spiritualhigh.co.uk/downloads/Legal-party-pills-in-New-Zealand-report.pdf" rel="nofollow">[1]</a></span><small><a href="../../../p/o/r/Portable_Document_Format_95a8.html" title="Portable Document Format">PDF</a>&#160;(230&#160;<a href="../../../k/i/b/Kibibyte.html" title="Kibibyte">KiB</a>)</small></li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> K. Brennan, A. Johnstone, P. Fitzmaurice, R. Lea, S. Schenk. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA). Drug and Alcohol Dependence (2006), doi:10.1016/j.drugalcdep.2006.10.016</li>
<li id="_note-8"><b><a href="#_ref-8" title="">^</a></b> Sect. 8 of Medicines Act 1968 - Schedule 3, SI 3144 The Medicines for Human Use (Marketing Authorisations Etc) Regulations 1994</li>
<li id="_note-9"><b><a href="#_ref-9" title="">^</a></b> <a href="http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&amp;useSecondary=true&amp;ssDocName=CON2024549&amp;ssTargetNodeId=389" class="external free" title="http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&amp;useSecondary=true&amp;ssDocName=CON2024549&amp;ssTargetNodeId=389" rel="nofollow">http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&amp;useSecondary=true&amp;ssDocName=CON2024549&amp;ssTargetNodeId=389</a></li>
<li id="_note-10"><b><a href="#_ref-10" title="">^</a></b> <span class="PDFlink"><a href="http://www.stanz.org.nz/images/ASSENT81.PDF" class="external text" title="http://www.stanz.org.nz/images/ASSENT81.PDF" rel="nofollow">Misuse of Drugs Amendment Act 2005</a></span><small><a href="../../../p/o/r/Portable_Document_Format_95a8.html" title="Portable Document Format">PDF</a>&#160;(81.3&#160;<a href="../../../k/i/b/Kibibyte.html" title="Kibibyte">KiB</a>)</small></li>
<li id="_note-11"><b><a href="#_ref-11" title="">^</a></b> Controlled Drugs and Substances Act</li>
</ol>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/n/Benzylpiperazine.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.deadiversion.usdoj.gov/drugs_concern/bzp_tmp/bzp_tmp.htm" class="external text" title="http://www.deadiversion.usdoj.gov/drugs_concern/bzp_tmp/bzp_tmp.htm" rel="nofollow">BZP information from the US DEA.</a></li>
<li><a href="http://www.stargateinternational.org/archives/DEA-Error.pdf" class="external text" title="http://www.stargateinternational.org/archives/DEA-Error.pdf" rel="nofollow">DEA error on BZP potency explained</a></li>
<li><a href="http://www.newscientist.com/channel/being-human/drugs-alcohol/mg19125711.000-mindaltering-drugs-does-legal-mean-safe.html" class="external text" title="http://www.newscientist.com/channel/being-human/drugs-alcohol/mg19125711.000-mindaltering-drugs-does-legal-mean-safe.html" rel="nofollow">New Scientist Story</a></li>
<li><a href="http://www.stargateinternational.org/60MinsStargateCroppedSmall.wmv" class="external text" title="http://www.stargateinternational.org/60MinsStargateCroppedSmall.wmv" rel="nofollow">60 minutes story on beginning of BZP industry in New Zealand</a></li>
<li><a href="http://www.ndp.govt.nz/committees/eacd/BZPpaper20045663.pdf" class="external text" title="http://www.ndp.govt.nz/committees/eacd/BZPpaper20045663.pdf" rel="nofollow">New Zealand Expert Advisory Committee on Drugs Advice to the Minister on Benzylpiperazine (BZP)</a> (<a href="../../../p/d/f/PDF_bcd1.html" title="PDF">PDF</a> file)</li>
<li><a href="http://www.critic.co.nz/showfeature.php?id=2208" class="external text" title="http://www.critic.co.nz/showfeature.php?id=2208" rel="nofollow">New Zealand student magazine (Critic) on effects of various formulations.</a></li>
<li><a href="http://www.spiritualhigh.co.uk/spiritualhigh.co.uk/downloads/Legal-party-pills-in-New-Zealand-report.pdf" class="external text" title="http://www.spiritualhigh.co.uk/spiritualhigh.co.uk/downloads/Legal-party-pills-in-New-Zealand-report.pdf" rel="nofollow">Article on NZ study of BZP use and side-effects.</a></li>
<li><a href="http://www.erowid.org/chemicals/bzp/bzp.shtml" class="external text" title="http://www.erowid.org/chemicals/bzp/bzp.shtml" rel="nofollow">Erowid BZP Vault</a></li>
</ul>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#ccccff;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../s/t/i/Template%7EStimulants_a3f8.html" title="Template:Stimulants"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../s/t/i/Template%7EStimulants_a3f8.html" class="external text" title="http://en.wikipedia.org../../../s/t/i/Template%7EStimulants_a3f8.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../s/t/i/Stimulant.html" title="Stimulant">Stimulants</a></b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><a href="../../../a/d/r/Adrafinil.html" title="Adrafinil">Adrafinil</a>, <a href="../../../a/m/p/Amphetamine.html" title="Amphetamine">Amphetamine</a> (speed), <a href="../../../a/r/m/Armodafinil.html" title="Armodafinil">Armodafinil</a>, <a href="../../../c/a/f/Caffeine.html" title="Caffeine">Caffeine</a>, <a href="../../../c/o/c/Cocaine.html" title="Cocaine">Cocaine</a>, <a href="../../../e/p/h/Ephedrine.html" title="Ephedrine">Ephedrine</a>, <a href="../../../e/p/i/Epinephrine.html" title="Epinephrine">Epinephrine</a> (adrenaline), <a href="../../../m/e/t/Methylphenidate.html" title="Methylphenidate">Methylphenidate</a>, <a href="../../../m/o/d/Modafinil.html" title="Modafinil">Modafinil</a>, <a href="../../../n/i/c/Nicotine.html" title="Nicotine">Nicotine</a></p>
<p><i>See also <a href="../../../s/y/m/Template%7ESympathomimetic_amines_89db.html" title="Template:Sympathomimetic amines">Sympathomimetic amines</a></i></p>
</div>
</div>

<!-- 
Pre-expand include size: 10909 bytes
Post-expand include size: 9368 bytes
Template argument size: 1946 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/e/n/Benzylpiperazine.html">http://en.wikipedia.org../../../b/e/n/Benzylpiperazine.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_February_2007_f7dc.html" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../s/e/r/Category%7ESerotonin_receptor_agonists_f222.html" title="Category:Serotonin receptor agonists">Serotonin receptor agonists</a></span> | <span dir='ltr'><a href="../../../s/t/i/Category%7EStimulants_32f4.html" title="Category:Stimulants">Stimulants</a></span> | <span dir='ltr'><a href="../../../p/i/p/Category%7EPiperazines_40d3.html" title="Category:Piperazines">Piperazines</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/e/n/Benzylpiperazine.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/e/n/Talk%7EBenzylpiperazine_c323.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Benzylpiperazine">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../pl/b/z/p/BZP_a98f.html">Polski</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 01:57, 31 March 2007 by Wikipedia user <a href="../../../b/k/0/User%7EBk0_a429.html" title="User:Bk0">Bk0</a>. Based on work by Wikipedia user(s) <a href="../../../c/a/c/User%7ECacycle_6f2f.html" title="User:Cacycle">Cacycle</a>, <a href="../../../m/e/o/User%7EMeodipt_4a57.html" title="User:Meodipt">Meodipt</a>, <a href="../../../s/t/a/User%7EStargateinternational_7664.html" title="User:Stargateinternational">Stargateinternational</a>, <a href="../../../m/r/_/User%7EMr_Bungle_f8c8.html" title="User:Mr Bungle">Mr Bungle</a>, <a href="../../../o/c/a/User%7EOcatecir_b47d.html" title="User:Ocatecir">Ocatecir</a>, <a href="../../../m/a/r/User%7EMartinBot_3f64.html" title="User:MartinBot">MartinBot</a>, <a href="../../../j/o/b/User%7EJobj%C3%B6rn_5bfe.html" title="User:Jobjörn">Jobjörn</a>, <a href="../../../e/d/g/User%7EEdgar181_7e9b.html" title="User:Edgar181">Edgar181</a>, <a href="../../../p/d/f/User%7EPDFbot_d220.html" title="User:PDFbot">PDFbot</a>, <a href="../../../n/o/1/User%7ENo1lakersfan_aff9.html" title="User:No1lakersfan">No1lakersfan</a>, <a href="../../../1/2E/1/User%7E1.1.1.html" title="User:1.1.1">1.1.1</a>, Waerloeg, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, Sanctuary scott, <a href="../../../g/e/n/User%7EGene_Nygaard_634f.html" title="User:Gene Nygaard">Gene Nygaard</a>, Sartorius, <a href="../../../t/h/e/User%7EThe_Rambling_Man_48d1.html" title="User:The Rambling Man">The Rambling Man</a>, Drella118, Junior Brian, <a href="../../../n/z/g/User%7ENzgabriel_ecaf.html" title="User:Nzgabriel">Nzgabriel</a>, <a href="../../../m/i/s/User%7EMiserlou_e394.html" title="User:Miserlou">Miserlou</a>, <a href="../../../n/i/h/User%7ENihiltres_9c42.html" title="User:Nihiltres">Nihiltres</a>, <a href="../../../m/e/t/User%7EMetsBot_6c59.html" title="User:MetsBot">MetsBot</a>, <a href="../../../j/e/r/User%7EJeremy_Nimmo_b295.html" title="User:Jeremy Nimmo">Jeremy Nimmo</a>, <a href="../../../a/e/r/User%7EAerodrome_8cb9.html" title="User:Aerodrome">Aerodrome</a>, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../s/a/g/User%7ESagabot_42ff.html" title="User:Sagabot">Sagabot</a>, NZUlysses, <a href="../../../u/r/o/User%7EUrod_afcd.html" title="User:Urod">Urod</a>, <a href="../../../v/o/x/User%7EVoxLuna_696b.html" title="User:VoxLuna">VoxLuna</a>, <a href="../../../b/w/h/User%7EBwhack_e9d6.html" title="User:Bwhack">Bwhack</a>, <a href="../../../t/u/r/User%7ETurkeyphant_c67c.html" title="User:Turkeyphant">Turkeyphant</a>, Marlboro1, <a href="../../../t/i/g/User%7ETigerShark_1e1f.html" title="User:TigerShark">TigerShark</a>, <a href="../../../a/l/a/User%7EAlan_Liefting_5801.html" title="User:Alan Liefting">Alan Liefting</a>, <a href="../../../a/v/r/User%7EAvriette_f119.html" title="User:Avriette">Avriette</a>, <a href="../../../g/l/e/User%7EGlen_9316.html" title="User:Glen">Glen</a>, <a href="../../../t/s/c/User%7ETsca.bot_2336.html" title="User:Tsca.bot">Tsca.bot</a>, Rare Hurtz, <a href="../../../x/c/o/User%7EXcomradex_e0dd.html" title="User:Xcomradex">Xcomradex</a>, <a href="../../../c/k/e/User%7ECKelly_f4a0.html" title="User:CKelly">CKelly</a>, <a href="../../../j/m/c/User%7EJmchuff_9962.html" title="User:Jmchuff">Jmchuff</a>, <a href="../../../s/c/e/User%7ESCEhardt_7145.html" title="User:SCEhardt">SCEhardt</a>, <a href="../../../t/r/i/User%7ETristanb_d761.html" title="User:Tristanb">Tristanb</a>, <a href="../../../f/i/r/User%7EFirstPrinciples_f0ae.html" title="User:FirstPrinciples">FirstPrinciples</a>, <a href="../../../m/o/i/User%7EMoink_dc9f.html" title="User:Moink">Moink</a>, AndreaGuerra and Dave au and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
